Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

The purpose of this study was to investigate the risk of thrombosis and bleeding according to multiple antithrombotic treatment regimens in atrial fibrillation (AF) patients after myocardial infarction (MI) or percutaneous coronary intervention (PCI). The optimal antithrombotic treatment strategy is...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American College of Cardiology Vol. 62; no. 11; p. 981
Main Authors:	Lamberts, Morten, Gislason, Gunnar H, Olesen, Jonas Bjerring, Kristensen, Søren Lund, Schjerning Olsen, Anne-Marie, Mikkelsen, Anders, Christensen, Christine Benn, Lip, Gregory Y H, Køber, Lars, Torp-Pedersen, Christian, Hansen, Morten Lock
Format:	Journal Article
Language:	English
Published:	United States 10.09.2013
Subjects:	Administration, Oral Aged Aged, 80 and over Anticoagulants - adverse effects Anticoagulants - therapeutic use Aspirin - adverse effects Aspirin - therapeutic use Atrial Fibrillation - complications Atrial Fibrillation - therapy Denmark - epidemiology Drug Therapy, Combination Female Humans Incidence Male Myocardial Infarction - epidemiology Myocardial Infarction - etiology Myocardial Infarction - prevention & control Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Postoperative Complications Registries Risk Factors Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome Denmark International Classification of Diseases bleeding AF CI oral anticoagulant myocardial infarction HR ICD stroke Anatomical Therapeutical Chemical ATC OAC atrial fibrillation percutaneous coronary intervention PCI hazard ratio confidence interval MI antithrombotic treatment
ISSN:	1558-3597, 1558-3597
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!